vs
Side-by-side financial comparison of GRID DYNAMICS HOLDINGS, INC. (GDYN) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $104.1M, roughly 2.0× GRID DYNAMICS HOLDINGS, INC.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -1.4%, a 58.8% gap on every dollar of revenue.
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
GDYN vs IDYA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $104.1M | $207.8M |
| Net Profit | $-1.5M | $119.2M |
| Gross Margin | 34.8% | — |
| Operating Margin | 61.7% | 52.2% |
| Net Margin | -1.4% | 57.4% |
| Revenue YoY | 3.7% | — |
| Net Profit YoY | -150.6% | 330.1% |
| EPS (diluted) | $-0.02 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $104.1M | — | ||
| Q4 25 | $106.2M | — | ||
| Q3 25 | $104.2M | $207.8M | ||
| Q2 25 | $101.1M | — | ||
| Q1 25 | $100.4M | — | ||
| Q4 24 | $100.3M | — | ||
| Q3 24 | $87.4M | $0 | ||
| Q2 24 | $83.0M | $0 |
| Q1 26 | $-1.5M | — | ||
| Q4 25 | $306.0K | — | ||
| Q3 25 | $1.2M | $119.2M | ||
| Q2 25 | $5.3M | — | ||
| Q1 25 | $2.9M | — | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $4.3M | $-51.8M | ||
| Q2 24 | $-817.0K | $-52.8M |
| Q1 26 | 34.8% | — | ||
| Q4 25 | 34.0% | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 34.1% | — | ||
| Q1 25 | 36.8% | — | ||
| Q4 24 | 36.9% | — | ||
| Q3 24 | 37.4% | — | ||
| Q2 24 | 35.6% | — |
| Q1 26 | 61.7% | — | ||
| Q4 25 | 0.5% | — | ||
| Q3 25 | -0.2% | 52.2% | ||
| Q2 25 | -0.1% | — | ||
| Q1 25 | -2.0% | — | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 0.0% | — |
| Q1 26 | -1.4% | — | ||
| Q4 25 | 0.3% | — | ||
| Q3 25 | 1.1% | 57.4% | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | -1.0% | — |
| Q1 26 | $-0.02 | — | ||
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.01 | $1.33 | ||
| Q2 25 | $0.06 | — | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $0.06 | — | ||
| Q3 24 | $0.05 | $-0.60 | ||
| Q2 24 | $-0.01 | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $327.5M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $530.1M | $1.1B |
| Total Assets | $605.0M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $327.5M | — | ||
| Q4 25 | $342.1M | — | ||
| Q3 25 | $338.6M | $786.9M | ||
| Q2 25 | $336.8M | — | ||
| Q1 25 | $325.5M | — | ||
| Q4 24 | $334.7M | — | ||
| Q3 24 | $231.3M | $920.0M | ||
| Q2 24 | $256.0M | $701.7M |
| Q1 26 | $530.1M | — | ||
| Q4 25 | $542.1M | — | ||
| Q3 25 | $537.7M | $1.1B | ||
| Q2 25 | $532.2M | — | ||
| Q1 25 | $517.4M | — | ||
| Q4 24 | $517.8M | — | ||
| Q3 24 | $400.2M | $1.2B | ||
| Q2 24 | $388.4M | $931.7M |
| Q1 26 | $605.0M | — | ||
| Q4 25 | $612.9M | — | ||
| Q3 25 | $613.2M | $1.2B | ||
| Q2 25 | $608.9M | — | ||
| Q1 25 | $590.9M | — | ||
| Q4 24 | $592.2M | — | ||
| Q3 24 | $477.3M | $1.2B | ||
| Q2 24 | $443.6M | $973.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $9.9M | — | ||
| Q3 25 | $7.0M | $142.2M | ||
| Q2 25 | $14.4M | — | ||
| Q1 25 | $9.4M | — | ||
| Q4 24 | $7.1M | — | ||
| Q3 24 | $9.2M | $-49.2M | ||
| Q2 24 | $10.7M | $-32.9M |
| Q1 26 | — | — | ||
| Q4 25 | $6.1M | — | ||
| Q3 25 | $2.9M | $142.2M | ||
| Q2 25 | $10.2M | — | ||
| Q1 25 | $6.0M | — | ||
| Q4 24 | $4.4M | — | ||
| Q3 24 | $5.9M | $-49.7M | ||
| Q2 24 | $8.0M | $-33.9M |
| Q1 26 | — | — | ||
| Q4 25 | 5.7% | — | ||
| Q3 25 | 2.8% | 68.4% | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | 4.4% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 9.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | — | ||
| Q3 25 | 3.9% | 0.0% | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 3.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 32.34× | — | ||
| Q3 25 | 5.92× | 1.19× | ||
| Q2 25 | 2.73× | — | ||
| Q1 25 | 3.21× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
